GB201604304D0 - Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease - Google Patents

Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease

Info

Publication number
GB201604304D0
GB201604304D0 GBGB1604304.4A GB201604304A GB201604304D0 GB 201604304 D0 GB201604304 D0 GB 201604304D0 GB 201604304 A GB201604304 A GB 201604304A GB 201604304 D0 GB201604304 D0 GB 201604304D0
Authority
GB
United Kingdom
Prior art keywords
crohn
disease
stem cells
adipose tissue
derived stromal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1604304.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tigenix SA
Original Assignee
Tigenix SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tigenix SA filed Critical Tigenix SA
Priority to GBGB1604304.4A priority Critical patent/GB201604304D0/en
Publication of GB201604304D0 publication Critical patent/GB201604304D0/en
Priority to CN202211257331.4A priority patent/CN115569151A/zh
Priority to HUE17160932A priority patent/HUE058739T2/hu
Priority to RS20220355A priority patent/RS63163B1/sr
Priority to SI201731122T priority patent/SI3219321T1/sl
Priority to DE102017002458.8A priority patent/DE102017002458B4/de
Priority to NO20170376A priority patent/NO345415B1/en
Priority to IL298107A priority patent/IL298107B2/en
Priority to EP17160932.4A priority patent/EP3219321B1/en
Priority to ES201700204A priority patent/ES2681774B1/es
Priority to PCT/IB2017/051468 priority patent/WO2017158509A1/en
Priority to AU2017232718A priority patent/AU2017232718B2/en
Priority to JP2018548356A priority patent/JP6931656B2/ja
Priority to BE2017/5156A priority patent/BE1024781B1/de
Priority to CN201780017154.3A priority patent/CN108883135B/zh
Priority to KR1020187029414A priority patent/KR102277789B1/ko
Priority to SG11201807404XA priority patent/SG11201807404XA/en
Priority to CA3017694A priority patent/CA3017694C/en
Priority to HRP20220539TT priority patent/HRP20220539T1/hr
Priority to US15/458,509 priority patent/US10357518B2/en
Priority to FR1752073A priority patent/FR3048614B1/fr
Priority to SG10202008992YA priority patent/SG10202008992YA/en
Priority to MX2018010699A priority patent/MX2018010699A/es
Priority to LTEP17160932.4T priority patent/LT3219321T/lt
Priority to ES17160932T priority patent/ES2911718T3/es
Priority to IL261730A priority patent/IL261730B2/en
Priority to GB1704065.0A priority patent/GB2548490B/en
Priority to PL17160932T priority patent/PL3219321T3/pl
Priority to RU2018131519A priority patent/RU2742308C2/ru
Priority to EP22163484.3A priority patent/EP4074322A1/en
Priority to NL2018512A priority patent/NL2018512B1/nl
Priority to DK17160932.4T priority patent/DK3219321T3/da
Priority to BR112018068493-7A priority patent/BR112018068493B1/pt
Priority to US16/452,321 priority patent/US11273182B2/en
Priority to JP2021083406A priority patent/JP2021119789A/ja
Priority to US17/671,479 priority patent/US12213998B2/en
Priority to CY20221100296T priority patent/CY1125513T1/el
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1604304.4A 2016-03-14 2016-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease Ceased GB201604304D0 (en)

Priority Applications (37)

Application Number Priority Date Filing Date Title
GBGB1604304.4A GB201604304D0 (en) 2016-03-14 2016-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
BR112018068493-7A BR112018068493B1 (pt) 2016-03-14 2017-03-14 Uso de células-tronco estromais
HRP20220539TT HRP20220539T1 (hr) 2016-03-14 2017-03-14 Stromalne matične stanice iz masnog tkiva za uporabu u liječenju refraktornih kompleksnih perianalnih fistula kod crohnove bolesti
US15/458,509 US10357518B2 (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease
RS20220355A RS63163B1 (sr) 2016-03-14 2017-03-14 Stromalne matične ćelije dobijene iz masnog tkiva za upotrebu u lečenju upornih kompleksnih perianalnih fistula kod kronove bolesti
SI201731122T SI3219321T1 (sl) 2016-03-14 2017-03-14 Iz adipoznega tkiva izpeljane stromalne matične celice za uporabo pri zdravljenju refraktarnih kompleksnih perianalnih fistul pri Crohnovi bolezni
DE102017002458.8A DE102017002458B4 (de) 2016-03-14 2017-03-14 Von adipösem gewebe stammende stromale stammzellen zur verwendung bei der behandlung behandlungsresistenter komplexer perianalfisteln bei morbus crohn
SG10202008992YA SG10202008992YA (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
IL298107A IL298107B2 (en) 2016-03-14 2017-03-14 Compounds containing stem cells derived from adipose tissue for use in the treatment of recurrent symptoms of complex rectal abscesses in Crohn's disease
EP17160932.4A EP3219321B1 (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
ES201700204A ES2681774B1 (es) 2016-03-14 2017-03-14 Células madre estromales derivadas de tejido adiposo para el uso en el tratamiento de fistulas perianales complejas en la enfermedad de Crohn
PCT/IB2017/051468 WO2017158509A1 (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
AU2017232718A AU2017232718B2 (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
JP2018548356A JP6931656B2 (ja) 2016-03-14 2017-03-14 クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞
BE2017/5156A BE1024781B1 (de) 2016-03-14 2017-03-14 Von adipösem gewebe stammende stromale stammzellen zur verwendung bei der behandlung behandlungsresistenter komplexer perianalfisteln bei morbus crohn
CN201780017154.3A CN108883135B (zh) 2016-03-14 2017-03-14 用于治疗克罗恩病的难治性、复杂性肛周瘘的脂肪组织来源的基质干细胞
KR1020187029414A KR102277789B1 (ko) 2016-03-14 2017-03-14 크론병의 난치성 복합 항문주위 누공 치료용 지방 조직 유래 기질 줄기 세포
SG11201807404XA SG11201807404XA (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
CA3017694A CA3017694C (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
CN202211257331.4A CN115569151A (zh) 2016-03-14 2017-03-14 用于治疗克罗恩病的难治性、复杂性肛周瘘的脂肪组织来源的基质干细胞
FR1752073A FR3048614B1 (fr) 2016-03-14 2017-03-14 Cellules souches stromales derivees du tissu adipeux pour une utilisation dans le traitement des fistules peri-anales complexes refractaires dans la maladie de crohn
HUE17160932A HUE058739T2 (hu) 2016-03-14 2017-03-14 Adipóz szövetbõl származó stromális õssejtek refrakter komplex perianális fisztulák kezelésében történõ alkalmazásra Crohn-betegségben
NO20170376A NO345415B1 (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease.
MX2018010699A MX2018010699A (es) 2016-03-14 2017-03-14 Celulas madre estromales derivadas del tejido adiposo para uso en el tratamiento de fistulas perianales complejas resistentes en enfermedad de crohn.
LTEP17160932.4T LT3219321T (lt) 2016-03-14 2017-03-14 Stromos kamieninės ląstelės, kilusios iš riebalinio audinio, skirtos panaudoti gydant atsparias gydymui kompleksines perianalines fistules krono ligos atveju
ES17160932T ES2911718T3 (es) 2016-03-14 2017-03-14 Células madre estromales derivadas de tejido adiposo para su uso en el tratamiento de fístulas perianales complejas resistentes en enfermedad de Crohn
IL261730A IL261730B2 (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn’s disease
GB1704065.0A GB2548490B (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease
PL17160932T PL3219321T3 (pl) 2016-03-14 2017-03-14 Zrębowe komórki macierzyste pochodzące z tkanki tłuszczowej do zastosowania do leczenia opornych złożonych przetok okołoodbytowych w chorobie leśniowskiego-crohna
RU2018131519A RU2742308C2 (ru) 2016-03-14 2017-03-14 Стромальные стволовые клетки жировой ткани для использования в лечении рефракторных сложных перианальных фистул при болезни крона
EP22163484.3A EP4074322A1 (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
NL2018512A NL2018512B1 (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn’s disease
DK17160932.4T DK3219321T3 (da) 2016-03-14 2017-03-14 Fedtvævsafledte stromale stamceller til anvendelse til behandling af refraktære komplekse perianale fistler ved crohns sygdom
US16/452,321 US11273182B2 (en) 2016-03-14 2019-06-25 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease
JP2021083406A JP2021119789A (ja) 2016-03-14 2021-05-17 クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞
US17/671,479 US12213998B2 (en) 2016-03-14 2022-02-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease
CY20221100296T CY1125513T1 (el) 2016-03-14 2022-04-20 Προερχομενα απο λιπωδη ιστο στρωματικα αρχεγονα κυτταρα για χρηση σε αγωγη δυσαγωγων περιπλοκων περιπρωκτικων συριγγιων σε νοσο toy crohn

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1604304.4A GB201604304D0 (en) 2016-03-14 2016-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease

Publications (1)

Publication Number Publication Date
GB201604304D0 true GB201604304D0 (en) 2016-04-27

Family

ID=55952284

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1604304.4A Ceased GB201604304D0 (en) 2016-03-14 2016-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
GB1704065.0A Active GB2548490B (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1704065.0A Active GB2548490B (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease

Country Status (27)

Country Link
US (3) US10357518B2 (cg-RX-API-DMAC10.html)
EP (2) EP3219321B1 (cg-RX-API-DMAC10.html)
JP (2) JP6931656B2 (cg-RX-API-DMAC10.html)
KR (1) KR102277789B1 (cg-RX-API-DMAC10.html)
CN (2) CN115569151A (cg-RX-API-DMAC10.html)
AU (1) AU2017232718B2 (cg-RX-API-DMAC10.html)
BE (1) BE1024781B1 (cg-RX-API-DMAC10.html)
CA (1) CA3017694C (cg-RX-API-DMAC10.html)
CY (1) CY1125513T1 (cg-RX-API-DMAC10.html)
DE (1) DE102017002458B4 (cg-RX-API-DMAC10.html)
DK (1) DK3219321T3 (cg-RX-API-DMAC10.html)
ES (2) ES2681774B1 (cg-RX-API-DMAC10.html)
FR (1) FR3048614B1 (cg-RX-API-DMAC10.html)
GB (2) GB201604304D0 (cg-RX-API-DMAC10.html)
HR (1) HRP20220539T1 (cg-RX-API-DMAC10.html)
HU (1) HUE058739T2 (cg-RX-API-DMAC10.html)
IL (2) IL261730B2 (cg-RX-API-DMAC10.html)
LT (1) LT3219321T (cg-RX-API-DMAC10.html)
MX (1) MX2018010699A (cg-RX-API-DMAC10.html)
NL (1) NL2018512B1 (cg-RX-API-DMAC10.html)
NO (1) NO345415B1 (cg-RX-API-DMAC10.html)
PL (1) PL3219321T3 (cg-RX-API-DMAC10.html)
RS (1) RS63163B1 (cg-RX-API-DMAC10.html)
RU (1) RU2742308C2 (cg-RX-API-DMAC10.html)
SG (2) SG10202008992YA (cg-RX-API-DMAC10.html)
SI (1) SI3219321T1 (cg-RX-API-DMAC10.html)
WO (1) WO2017158509A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
GB201604304D0 (en) * 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
WO2018183941A2 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with live biotherapeutics
JP7628499B2 (ja) * 2019-02-27 2025-02-10 武田薬品工業株式会社 同種異系療法のための改良された幹細胞集団
CN115297875A (zh) * 2020-03-11 2022-11-04 迈索布拉斯特国际有限公司 治疗炎症性肠病的方法ii
BR112022017560A2 (pt) * 2020-03-11 2022-12-27 Mesoblast Int Sarl Método para tratar doença inflamatória intestinal i
CN111481573A (zh) * 2020-03-26 2020-08-04 卡替(上海)生物技术股份有限公司 牙髓间充质干细胞在制备克罗恩病治疗药物中的用途
CN116801892A (zh) * 2020-11-25 2023-09-22 旗舰创业股份有限公司 脂肪生成细胞组合物和方法
CA3200227A1 (en) * 2020-11-25 2022-06-02 Alexandra Sophie DE BOER Adipogenic cell compositions and methods
EP4531879A1 (en) * 2022-05-25 2025-04-09 Flagship Pioneering Innovations VI, LLC Compositions of secretory and/or catalytic cells and methods using the same

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5733542A (en) 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US6010696A (en) 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
FR2680931B1 (fr) 1991-08-27 1997-08-14 Thomson Csf Procede de detection et de suivi d'objets en mouvement par analyse de sequences d'images.
ATE163921T1 (de) 1992-12-02 1998-03-15 Shell Int Research Azoxycyanbenzol-derivate
WO1995002698A1 (en) 1993-07-12 1995-01-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
US5472183A (en) 1994-03-17 1995-12-05 Nisca Corporation Sheet feeding device with multiple sheet stackers
ES2206509T3 (es) 1994-06-06 2004-05-16 Case Western Reserve University Biomatriz para la regeneracion de tejidos.
US6174333B1 (en) 1994-06-06 2001-01-16 Osiris Therapeutics, Inc. Biomatrix for soft tissue regeneration using mesenchymal stem cells
JP4335310B2 (ja) 1995-06-07 2009-09-30 ザ ユニバーシティ オブ ブリティッシュ コロンビア 疎水性脂質−核酸複合中間体を通して調製される脂質−核酸粒子、及び遺伝子移送のための使用
US6051429A (en) 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
US6546106B2 (en) 1996-09-03 2003-04-08 New Transducers Limited Acoustic device
US5705308A (en) 1996-09-30 1998-01-06 Eastman Kodak Company Infrared-sensitive, negative-working diazonaphthoquinone imaging composition and element
CN1166773C (zh) 1997-12-02 2004-09-15 泽恩比奥公司 分离的人脂肪组织衍生的基质细胞
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US9585916B2 (en) 1999-03-26 2017-03-07 Northern Therapeutics Inc. Cell based therapy for the pulmonary system
JP2002510655A (ja) 1998-04-03 2002-04-09 オシリス セラピューティクス,インコーポレイテッド 免疫抑制剤としての間葉幹細胞によるt細胞応答を阻害する方法とその利用
US6546105B1 (en) 1998-10-30 2003-04-08 Matsushita Electric Industrial Co., Ltd. Sound image localization device and sound image localization method
US20050153442A1 (en) 1999-03-10 2005-07-14 Adam Katz Adipose-derived stem cells and lattices
RU2306335C2 (ru) 1999-03-10 2007-09-20 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Стволовые клетки и решетки, полученные из жировой ткани
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20030082152A1 (en) 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
CN1201268C (zh) 1999-06-30 2005-05-11 国际商业机器公司 实现运动模糊化的图像处理
US7670628B2 (en) 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
US6555374B1 (en) 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
US20020155096A1 (en) 2001-02-23 2002-10-24 Chancellor Michael B. Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
JP2005533480A (ja) * 2001-11-09 2005-11-10 アーテセル・サイエンシズ・インコーポレーテツド 脂肪組織由来間質細胞の膵内分泌分化およびその使用
CN1596303A (zh) 2001-11-09 2005-03-16 阿特塞尔科学公司 利用基质细胞支持胚胎干细胞和成体干细胞的方法和组合物
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
US7282222B2 (en) 2002-03-15 2007-10-16 The United States Of America As Represented By The Department Of Veterans Affairs Methods and compositions for directing cells to target organs
AU2003239016B2 (en) 2002-06-14 2007-09-20 Xintela Ab Marker for stem cells and its use
US20040101959A1 (en) 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells
WO2004090112A2 (en) 2003-04-01 2004-10-21 United States Of America Department Of Veteran's Affairs Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
ES2265199B1 (es) 2003-06-12 2008-02-01 Cellerix, S.L. Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones.
ES2569780T3 (es) 2003-06-27 2016-05-12 DePuy Synthes Products, Inc. Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas
US7645229B2 (en) 2003-09-26 2010-01-12 Armstrong David N Instrument and method for endoscopic visualization and treatment of anorectal fistula
JP4749331B2 (ja) 2003-10-07 2011-08-17 株式会社バイオマスター 脂肪由来前駆細胞の細胞分化
US9631176B2 (en) 2003-11-04 2017-04-25 Biomaster, Inc. Method for preparing stem cells from fat tissue
CA2564679C (en) 2004-03-22 2015-06-23 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
US20080095749A1 (en) 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
RU2252252C1 (ru) 2004-04-09 2005-05-20 Тепляшин Александр Сергеевич Способ выделения мезенхимальных стволовых клеток
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
ES2313805B1 (es) 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
ES2264862B8 (es) 2004-08-25 2017-01-20 Cellerix, S.L. Biomaterial para sutura.
WO2006029347A2 (en) 2004-09-03 2006-03-16 University Of Maryland, Baltimore Integrin cd18 is a novel stromal stem cell marker and functions to promote osteogenesis
US20060286089A1 (en) 2005-04-08 2006-12-21 Xcyte Therapies, Inc. Compositions and methods for the treatment of burns and sepsis
SG10202001007TA (en) 2005-09-23 2020-03-30 Tigenix Sau Cell populations having immunoregulatory activity, method for isolation and uses
EP1795588A1 (en) 2005-12-07 2007-06-13 Cellerix, S.L. Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
US20120269774A1 (en) 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
EP2191835A4 (en) 2007-09-07 2011-12-14 Japan Chem Res THERAPEUTIC AND PROPHYLACTIC AGENTS FOR ARTHRITIS
ES2392729T5 (es) 2007-09-19 2015-08-28 Pluristem Ltd. Células adherentes de tejidos adiposos o de placenta y uso de las mismas en terapia
ES2595103T3 (es) 2007-10-17 2016-12-27 Txcell Células Tr1, células madre mesenquimales y usos de estas
GB0814249D0 (en) 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
ES2345867B1 (es) * 2009-04-03 2011-07-28 Fundacion Instituto Mediterraneo Para La Biotecnologia Y La Investigacion Sanitaria (Imabis) Celulas madre multipotentes derivadas de estroma de mesenterio.
WO2010126194A1 (ko) * 2009-04-28 2010-11-04 (주) 안트로젠 누공 치료를 위한 자가 및 동종의 지방 유래 스트로마 줄기세포 조성물
HUE031921T2 (en) 2009-07-09 2017-08-28 Tigenix S A U Methods and preparations for use in cell therapy
CA2818024C (en) * 2010-12-06 2019-09-24 Quark Pharmaceuticals, Inc. Double stranded oligonucleotide compounds comprising positional modifications
JP6018081B2 (ja) 2011-01-12 2016-11-02 ティジェニクス エス.エー.ユー. 自己免疫および炎症性疾患におけるリンパ系内投与用の脂肪由来間葉系幹細胞
KR20140016933A (ko) 2011-03-11 2014-02-10 타이제닉스, 에스.에이.유. 면역조절 활성을 갖는 세포군, 분리방법 및 용도들
US20140134140A1 (en) 2012-11-09 2014-05-15 Case Western Reserve University Mesenchymal stem cell compositions for the treatment of microbial infections
ES2748825T3 (es) * 2013-03-15 2020-03-18 Tigenix S A U Biomarcadores de linfocitos para determinar la respuesta clínica a la terapia celular
US20160120910A1 (en) 2013-06-25 2016-05-05 Tigenix S.A.U. Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
KR102213527B1 (ko) * 2014-06-30 2021-02-09 타이제닉스, 에스.에이.유. 패혈증 치료용 중간엽 기질세포
US11578306B2 (en) * 2015-09-24 2023-02-14 Cellect Biotherapeutics Ltd. Methods for propagating mesenchymal stem cells (MSC) for use in transplantation
GB201604304D0 (en) * 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
US10152822B2 (en) 2017-04-01 2018-12-11 Intel Corporation Motion biased foveated renderer
US10890966B2 (en) 2017-07-27 2021-01-12 Arm Limited Graphics processing systems
US10818080B2 (en) 2018-07-25 2020-10-27 Disney Enterprises, Inc. Piecewise-polynomial coupling layers for warp-predicting neural networks
US11109065B2 (en) 2018-09-26 2021-08-31 Google Llc Video encoding by providing geometric proxies

Also Published As

Publication number Publication date
IL261730B2 (en) 2024-05-01
SI3219321T1 (sl) 2022-05-31
NL2018512B1 (en) 2017-09-07
BE1024781B1 (de) 2018-07-02
NL2018512A (en) 2017-03-30
GB2548490B (en) 2020-09-02
KR102277789B1 (ko) 2021-07-15
NO20170376A1 (en) 2017-09-15
KR20180120261A (ko) 2018-11-05
FR3048614A1 (cg-RX-API-DMAC10.html) 2017-09-15
JP2021119789A (ja) 2021-08-19
ES2681774A1 (es) 2018-09-14
IL298107A (en) 2023-01-01
ES2681774B1 (es) 2019-12-26
US20220249574A1 (en) 2022-08-11
HUE058739T2 (hu) 2022-09-28
BE1024781A1 (de) 2018-06-27
CA3017694A1 (en) 2017-09-21
MX2018010699A (es) 2019-01-14
AU2017232718B2 (en) 2024-01-18
US20170258851A1 (en) 2017-09-14
US11273182B2 (en) 2022-03-15
US12213998B2 (en) 2025-02-04
DK3219321T3 (da) 2022-04-25
US10357518B2 (en) 2019-07-23
IL298107B2 (en) 2024-02-01
CN115569151A (zh) 2023-01-06
RU2742308C2 (ru) 2021-02-04
CN108883135A (zh) 2018-11-23
LT3219321T (lt) 2022-05-10
CN108883135B (zh) 2022-11-04
EP4074322A1 (en) 2022-10-19
DE102017002458B4 (de) 2019-04-25
GB2548490A (en) 2017-09-20
GB201704065D0 (en) 2017-04-26
RU2018131519A (ru) 2020-04-15
BR112018068493A8 (pt) 2022-06-28
US20190381106A1 (en) 2019-12-19
IL298107B1 (en) 2023-10-01
SG10202008992YA (en) 2020-10-29
JP6931656B2 (ja) 2021-09-08
SG11201807404XA (en) 2018-09-27
WO2017158509A1 (en) 2017-09-21
IL261730B1 (en) 2024-01-01
IL261730A (en) 2018-10-31
JP2019508455A (ja) 2019-03-28
DE102017002458A1 (de) 2017-09-14
AU2017232718A1 (en) 2018-10-04
RS63163B1 (sr) 2022-05-31
CY1125513T1 (el) 2024-12-13
BR112018068493A2 (pt) 2019-01-22
ES2911718T3 (es) 2022-05-20
RU2018131519A3 (cg-RX-API-DMAC10.html) 2020-07-10
EP3219321A1 (en) 2017-09-20
CA3017694C (en) 2024-02-27
EP3219321B1 (en) 2022-03-30
NO345415B1 (en) 2021-01-18
FR3048614B1 (fr) 2020-02-21
HRP20220539T1 (hr) 2022-06-10
PL3219321T3 (pl) 2022-05-30

Similar Documents

Publication Publication Date Title
GB2548490B (en) Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease
SG10201606170SA (en) Estimating Vessel Intent
IL236054B (en) Compositions and methods for treating Crohn's disease and related conditions and infections
IL253389A0 (en) The composition for use in increasing the assembly efficiency of "haematopoietic" stem cells after transplantation
ZA202203445B (en) Compositions for use in treating hypoxia inducible factor (hif)-related conditions
PL3522904T3 (pl) Ciekła kompozycja do stosowania w leczeniu refluksu żołądkowo- przełykowego
GB201403969D0 (en) Compounds for use in controlling body fat
IL251605B (en) Use of protein in predicting intra-corporeal phenomena
PL3377909T3 (pl) Laktoferyna do zastosowania w diagnozowaniu lub prognozowaniu choroby Alzheimera
PL3132020T3 (pl) Naczynie do hodowli komórek i jego zastosowanie
SG11201701648UA (en) Use of cysteamine in treating infections caused by yeasts/moulds
FR3020758B1 (fr) Composition pour ameliorer l'hygiene buco-dentaire
LT3423060T (lt) Imatinibas, skirtas naudoti insulto gydymui
FR3030253B1 (fr) Composition pour ameliorer l'aspect cellulitique de la peau
HK1242602B (en) Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
PL2999664T3 (pl) Sposób obróbki żużli z wtórnego wytopu aluminium
IL252109A0 (en) (pigment epithelium derived factor (pedf) for the treatment of uterine fibroids
IL256880A (en) Combining proteins for the diagnosis of schizophrenia
ZA201801788B (en) Lysobactin for use in the treatment of bovine mastitis
Lambert Techniques to reduce the solution time of the open pit block sequencing problem
FR3028248B3 (fr) Poignee pour bidon
TWM489511U (en) The underpants for improving the abilities of men in sexing
IL251040A0 (en) Using cysteamine to treat infections caused by yeasts/molds
GB201409557D0 (en) Tub and bucket trolley
ZA201408464B (en) Composition for the use in treatment of asthma

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)